TNFRSF13B and Miyoshi myopathy: Further, the TriPRIL CAR T cells were able to eradicate BCMA-knock-out MM cells in comparison to treatment with traditional BCMA CAR T cells and the non-trimeric CAR T cells, further demonstrating the importance of dual-targeting of TACI in the MM setting.